课题基金 / 基金详情

21EBTA: EB-AI Consortium for Bioengineered Cells & Systems (AI-4-EB)

21EBTA: EB-AI Consortium for Bioengineered Cells & Systems (AI-4-EB)
21EBTA:EB-AI 生物工程细胞联盟
批准号:
BB/W013770/1
负责人:
Geoffrey Baldwin
金额:
$160.5万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --

项目摘要

项目成果

Geoffrey Baldwin的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Our vision for this Transition Award is to leverage and combine key emerging technologies in Artificial Intelligence (AI) and Engineering Biology (EB) to enable and pioneer a new era of world-leading advances that will directly contribute to the objectives of the National Engineering Biology Programme. Realisation of the benefits of Engineering Biology technologies is predicated on our ability to increase our capability for predictive design and optimisation of engineered biosystems across different biological scales. Such a scaled approach to Engineering Biology would serve to significantly accelerate translation of scientific research and innovation into applications of wide commercial and societal impact.Synthetic Biology has developed rapidly over the past decade. We now have the core tools and capabilities required to modify and engineer living systems. However, our ability to predictably design new biological systems is still limited, due to the complexity, noise, and context dependence inherent to biology. To achieve the full capability of Engineering Biology, we require a change in capacity and scope. This requires lab automation to deliver high-throughput workflows. With this comes the challenge of managing and utilising the data-rich environment of biology that has emerged from recent advances in data collection capabilities, which include high-throughput genomics, transcriptomics, and metabolomics. However, such approaches produce datasets that are too large for direct human interpretation. There is thus a need to develop deep statistical learning and inference methods to uncover patterns and correlations within these data. On the other hand, steady improvements in computing power, combined with recent advances in data and computer sciences have fuelled a new era of Artificial Intelligence (AI)-driven methods and discoveries that are progressively permeating almost all sectors and industries. However, the type of data we can gather from biological systems does not match the requirements for off-the-shelf ML/AI methods and tools that are currently available. This calls for the development of new bespoke AI/ML methods adapted to the specific features of biological measurement data. AI approaches have the potential to both learn from complex data and, when coupled to appropriate systems design and engineering methods, to provide the predictive power required for reliable engineering of biological systems with desired functions. As the field develops, there is thus an opportunity to strategically focus on data-centric approaches and AI-enabled methods that are appropriate to the challenges and themes of the National Engineering Biology Programme. Closing the Design-Build-Test-Learn loop using AI to direct the "learn" and "design" phases will provide a radical intervention that fundamentally changes the way that we design, optimise and build biological systems.Through this AI-4-EB Transition Award we will build a network of inter-connected and inter-disciplinary researchers to both develop and apply next-generation AI technologies to biological problems. This will be achieved through a combination of leading-light inter-disciplinary pilot projects for application-driven research, meetings to build the scientific community, and sandpits supported by seed funding to generate novel ideas and new collaborations around AI approaches for real-world use. We will also develop an RRI strategy to address the complex issues arising at the confluence of these two critical and transformative technologies. Overall, AI-4-EB will provide the necessary step-change for the analysis of large and heterogeneous biological data sets, and for AI-based design and optimisation of biological systems with sufficient predictive power to accelerate Engineering Biology.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1162/qss_a_00285
发表时间: 2024-03-01
期刊: QUANTITATIVE SCIENCE STUDIES
影响因子: 6.4
作者: [Pelaez,Sergio, Verma,Gaurav, Shapira,Philip]
通讯作者: Shapira,Philip
DOI: 10.48550/arxiv.2306.05143
发表时间: 2023-06
期刊: ArXiv
影响因子: --
作者: [Zehui Li;Akashaditya Das;W. Beardall;Yiren Zhao;G. Stan]
通讯作者: Zehui Li;Akashaditya Das;W. Beardall;Yiren Zhao;G. Stan
DOI: 10.1371/journal.pcbi.1010988
发表时间: 2023-04
期刊: PLoS computational biology
影响因子: 4.3
作者: []
通讯作者:
Engineered sensor bacteria evolve master-level gameplay through accelerated adaptation
工程传感器细菌通过加速适应进化出大师级的游戏玩法
DOI: 10.1101/2022.04.22.489191
发表时间: 2022
期刊:
影响因子: --
作者: [Prakash S]
通讯作者: Prakash S
Using AI based modelling to drive the engineering of biology
  • 批准号:
    BB/Y514056/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $32.91万
  • 财政年份:
    2024
  • 负责人:
    Geoffrey Baldwin
  • 依托单位:
A semi-autonomous robot synthetic biologist for industrial biodesign and manufacturing
  • 批准号:
    EP/R034915/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $112.66万
  • 财政年份:
    2018
  • 负责人:
    Geoffrey Baldwin
  • 依托单位:
14TSB_SynBio Automated Gene Assembly From Codons to Complete Genes and Pathways
  • 批准号:
    BB/M00550X/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $13.14万
  • 财政年份:
    2014
  • 负责人:
    Geoffrey Baldwin
  • 依托单位:
Logic-directed evolution of new biosensor molecules in vivo
  • 批准号:
    BB/J020036/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $16.23万
  • 财政年份:
    2012
  • 负责人:
    Geoffrey Baldwin
  • 依托单位:
国内基金
海外基金
EB病毒核抗原1通过靶向PPP1CA稳定自身表达及其调控EBV潜伏感染的作用和机制研究
  • 批准号:
    2026JJ50144
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    卢建红
  • 依托单位:
CPP增强的AAV-PHP.eB递送联合VEGFA及其受体的多基因编辑技术精准治疗角膜新生血管
  • 批准号:
    2026JJ60599
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    郭淑佳
  • 依托单位:
EB病毒类朊蛋白EBNA1通过分子伴侣HSP90调控相分离促进鼻咽癌恶性进展的机制研究
  • 批准号:
    2026JJ60271
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    张宵月
  • 依托单位:
靶向EB病毒EBNA1、EBNA2相分离抑制鼻咽癌恶性表型的研究
  • 批准号:
    2026JJ30148
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    马健
  • 依托单位: